
Alkem Laboratories and IIT Bombay Collaborate for Advanced Research Centre in Immuno-Therapeutics and Regenerative Medicines
Alkem Laboratories Ltd, through its CSR arm Alkem Foundation, has partnered with the Indian Institute of Technology Bombay (IIT Bombay) to establish a first-of-its-kind research centre in India dedicated to immuno-therapeutics and regenerative medicines. Alkem Foundation will fund the establishment of 'Alkem Centre for Advanced Research and Development of Applied Immuno-Therapeutics and Regenerative Medicines' in the IIT Bombay campus, contributing a substantial 20-25% of its cumulative CSR obligations over seven years. This collaboration aims to foster cutting-edge research and innovation in complex disease areas, build a comprehensive ecosystem for innovation, research, and skill development, and strengthen India's translational research ecosystem in life sciences.
Key Highlights
- Alkem Laboratories and IIT Bombay announce a strategic collaboration to set up a research centre for immuno-therapeutics and regenerative medicines.
- Alkem Foundation will fund the establishment of the research centre with a substantial contribution over seven years.
- The research centre will foster cutting-edge research and innovation in complex disease areas.
- The centre aims to build a comprehensive ecosystem for innovation, research, and skill development in life sciences.
- The collaboration will strengthen India's translational research ecosystem in life sciences.